Tumor-Derived Exosomes in Tumor-Induced Immune Suppression
- PMID: 35163380
- PMCID: PMC8836190
- DOI: 10.3390/ijms23031461
Tumor-Derived Exosomes in Tumor-Induced Immune Suppression
Abstract
Exosomes are a class of small membrane-bound extracellular vesicles released by almost all cell types and present in all body fluids. Based on the studies of exosome content and their interactions with recipient cells, exosomes are now thought to mediate "targeted" information transfer. Tumor-derived exosomes (TEX) carry a cargo of molecules different from that of normal cell-derived exosomes. TEX functions to mediate distinct biological effects such as receptor discharge and intercellular cross-talk. The immune system defenses, which may initially restrict tumor progression, are progressively blunted by the broad array of TEX molecules that activate suppressive pathways in different immune cells. Herein, we provide a review of the latest research progress on TEX in the context of tumor-mediated immune suppression and discuss the potential as well as challenges of TEX as a target of immunotherapy.
Keywords: immune suppression; tumor microenvironment; tumor-derived exosomes.
Conflict of interest statement
The authors declare no potential conflict of interest.
Figures



References
-
- Pavlyukov M.S., Yu H., Bastola S., Minata M., Shender V.O., Lee Y., Zhang S., Wang J., Komarova S., Wang J., et al. Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors. Cancer Cell. 2018;34:119–135.e10. doi: 10.1016/j.ccell.2018.05.012. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- Accelerating Excellence in Translational Science Pilot Grants G0814C01 (Q. Hao) and G0812D05 (Y. Wu)/MD/NIMHD NIH HHS/United States
- 1U54CA14393 and NIH/NIMHD U54MD007598 (J.V. Vadgama)/CA/NCI NIH HHS/United States
- U54 MD007598/MD/NIMHD NIH HHS/United States
- U24 MD015970/MD/NIMHD NIH HHS/United States
- 1R03CA208221 and 1SC1GM121202, 5S21MD000103 (P. Wang)/NH/NIH HHS/United States
- SC1CA200517 and 9 SC1 GM135050-05 (Y. Wu)/CA/NCI NIH HHS/United States
- SC1 CA200517/CA/NCI NIH HHS/United States
- CTSI UL1TR000124 (J.V. Vadgama)./TR/NCATS NIH HHS/United States
- SC1 GM135050/GM/NIGMS NIH HHS/United States
- Breast Cancer Research Program grant BC043180 (J.V. Vadgama)/United States Department of Defense
LinkOut - more resources
Full Text Sources
Medical